Savior Lifetec Corporation (TPEX:4167)

Market Cap	6.11B
Revenue (ttm)	1.22B
Net Income (ttm)	182.38M
Shares Out	317.40M
EPS (ttm)	0.57
PE Ratio	33.77
Forward PE	n/a
Dividend	0.09 (0.44%)
Ex-Dividend Date	n/a

Volume	778,692
Average Volume	1,127,059
Open	19.15
Previous Close	19.15
Day's Range	19.00 - 19.30
52-Week Range	14.35 - 27.80
Beta	0.60
RSI	57.19
Earnings Date	May 8, 2025

About Savior Lifetec

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Miaoli County, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 384
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4167

Financial Performance

In 2024, Savior Lifetec's revenue was 1.22 billion, an increase of 15.91% compared to the previous year's 1.05 billion. Earnings were 182.38 million, an increase of 507.33%.